Editorial Policy & Fact-Checking Standard

All pharmacological data presented on this platform is compiled from peer-reviewed pharmacological literature and verified national formularies.

Primary Reference Sources

• Indian Pharmacopoeia (IP) — Published by the Indian Pharmacopoeia Commission (IPC), Ministry of Health & Family Welfare.
• Central Drugs Standard Control Organisation (CDSCO) — Regulatory authority under India's Drugs and Cosmetics Act, 1940.
• WHO Essential Medicines List — Global benchmark for safe, effective, cost-effective medicines.
• PMBJP (Jan Aushadhi) Formulary — Official generic medicine pricing from the Bureau of Pharma PSUs of India (BPPI).
• National Library of Medicine / PubMed — Peer-reviewed clinical literature for drug interaction and efficacy data.

Content Review Process

MediMatch AI remains an educational reference tool and does not replace consultation with a licensed physician or pharmacist.

1. Initial Research: Drug information sourced from IP monographs, CDSCO drug databases, and manufacturer prescribing information.
2. Cross-verification: Dosage, indication, contraindication, and interaction data cross-checked against at least two independent reference sources.
3. Clinical Review: Drug interaction alerts reviewed against established pharmacokinetic literature to confirm clinical significance.
4. Update Cycle: Drug data reviewed whenever CDSCO issues new drug alerts, recalls, or when significant new clinical evidence emerges.

Medical Disclaimer

MediMatch AI is an educational reference platform. It does not provide medical diagnoses, treatment recommendations, or replace consultation with a licensed physician or pharmacist. All information is for educational purposes only.

Report an Error

If you identify a factual error or outdated drug information, contact: editorial@medimatchai.in. We aim to respond within 5 business days.